Compare PNW & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PNW | CRL |
|---|---|---|
| Founded | 1985 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.8B | 10.8B |
| IPO Year | 1994 | 1999 |
| Metric | PNW | CRL |
|---|---|---|
| Price | $97.52 | $288.50 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 15 | 12 |
| Target Price | $100.21 | ★ $198.27 |
| AVG Volume (30 Days) | 732.2K | ★ 848.5K |
| Earning Date | 05-04-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.58% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.70 | N/A |
| Revenue | ★ $5,339,939,000.00 | $1,857,601,000.00 |
| Revenue This Year | $5.15 | N/A |
| Revenue Next Year | $6.89 | $3.04 |
| P/E Ratio | $57.55 | ★ N/A |
| Revenue Growth | 4.20 | ★ 10.48 |
| 52 Week Low | $85.32 | $144.26 |
| 52 Week High | $111.16 | $303.31 |
| Indicator | PNW | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 37.56 | 61.92 |
| Support Level | $97.54 | $215.89 |
| Resistance Level | $103.02 | $303.31 |
| Average True Range (ATR) | 1.42 | 9.54 |
| MACD | 0.07 | -2.67 |
| Stochastic Oscillator | 26.40 | 43.54 |
Pinnacle West is a holding company whose principal subsidiary is Arizona Public Service, a vertically integrated electric utility serving approximately 1.4 million customers across a 35,000-square-mile territory in central Arizona, including the Phoenix area. APS owns or leases 6.5 gigawatts of power generation capacity, including a 29% ownership stake in one of the largest nuclear plants in the US, Palo Verde. Half of the electricity that APS supplies to customers comes from clean energy sources, including nuclear.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.